Early closure compared to late closure of temporary ileostomy in rectal cancer: a randomized controlled trial study.
Closure of ileostomy
Low anterior resection
Low anterior resection syndrome (LARS)
Quality of life (QOL)
Rectal cancer
Journal
Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285
Informations de publication
Date de publication:
14 Jun 2023
14 Jun 2023
Historique:
received:
23
07
2022
accepted:
07
05
2023
medline:
16
6
2023
pubmed:
15
6
2023
entrez:
14
6
2023
Statut:
epublish
Résumé
A temporary loop ileostomy is one of the most common methods for the prevention of anastomotic leakage in rectal cancer patients who underwent low anterior resection. However, the optimal timing of loop ileostomy reversal remains unknown. The main objective of this study was to evaluate the debilitating complications caused by early closure of ileostomy in comparison with late closure in rectal cancer patients. A randomized, controlled, unblinded, and monocentric trial. A total of 104 rectal cancer patients were randomly assigned to the case group of early closure of ileostomy (n = 50) and the control group of late closure of ileostomy (n = 54). This trial was undertaken in a single colorectal institution, a university-affiliated teaching hospital in Tehran, Iran. Randomization and allocation to the trial group were conducted by using variable block randomization based on quadruple numbers. The primary endpoint of this trial was determined by the complications of early ileostomy closure versus those of late closure in rectal cancer patients who had undergone low anterior resection. In early closure, loop ileostomy is reversed 2-3 weeks after the first two courses of adjuvant chemotherapy, while in late closure, the ileostomy is reversed 2-3 weeks after the last course of adjuvant chemotherapy. Follow-up of 1 year demonstrated a reduction in the risk of complications and an improved quality of life in patients with rectal cancer following low anterior resection and chemotherapy (neoadjuvant and adjuvant) in the case group but did not reach a significant difference (p = 0.555). In addition, there was no significant difference in perioperative outcomes, such as blood loss, operative time, readmission, and reoperation; also, no statistically significant differences were reported between the groups in patients' quality of life or LARS score. In summary, it seems that early closure of ileostomy is not better than late closure in improving patients' quality of life with rectal cancer following low anterior resection and chemotherapy (neoadjuvant and adjuvant); no statistical difference was observed for reduction of risk of ostomy complications. Thus, neither of these methods (early closure versus late closure) is superior to the other, and controversy still exists. IRCT20201113049373N1.
Sections du résumé
BACKGROUND
BACKGROUND
A temporary loop ileostomy is one of the most common methods for the prevention of anastomotic leakage in rectal cancer patients who underwent low anterior resection. However, the optimal timing of loop ileostomy reversal remains unknown. The main objective of this study was to evaluate the debilitating complications caused by early closure of ileostomy in comparison with late closure in rectal cancer patients.
DESIGN
METHODS
A randomized, controlled, unblinded, and monocentric trial.
METHODS
METHODS
A total of 104 rectal cancer patients were randomly assigned to the case group of early closure of ileostomy (n = 50) and the control group of late closure of ileostomy (n = 54). This trial was undertaken in a single colorectal institution, a university-affiliated teaching hospital in Tehran, Iran. Randomization and allocation to the trial group were conducted by using variable block randomization based on quadruple numbers. The primary endpoint of this trial was determined by the complications of early ileostomy closure versus those of late closure in rectal cancer patients who had undergone low anterior resection. In early closure, loop ileostomy is reversed 2-3 weeks after the first two courses of adjuvant chemotherapy, while in late closure, the ileostomy is reversed 2-3 weeks after the last course of adjuvant chemotherapy.
RESULTS
RESULTS
Follow-up of 1 year demonstrated a reduction in the risk of complications and an improved quality of life in patients with rectal cancer following low anterior resection and chemotherapy (neoadjuvant and adjuvant) in the case group but did not reach a significant difference (p = 0.555). In addition, there was no significant difference in perioperative outcomes, such as blood loss, operative time, readmission, and reoperation; also, no statistically significant differences were reported between the groups in patients' quality of life or LARS score.
CONCLUSION
CONCLUSIONS
In summary, it seems that early closure of ileostomy is not better than late closure in improving patients' quality of life with rectal cancer following low anterior resection and chemotherapy (neoadjuvant and adjuvant); no statistical difference was observed for reduction of risk of ostomy complications. Thus, neither of these methods (early closure versus late closure) is superior to the other, and controversy still exists.
TRIAL REGISTRATION NUMBER AND DATE OF REGISTRATION
UNASSIGNED
IRCT20201113049373N1.
Identifiants
pubmed: 37316696
doi: 10.1007/s00423-023-02934-0
pii: 10.1007/s00423-023-02934-0
doi:
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
234Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Karahasanoglu T et al (2011) Evaluation of diverting ileostomy in laparoscopic low anterior resection for rectal cancer. Asian J Surg 34(2):63–68
doi: 10.1016/S1015-9584(11)60021-3
pubmed: 21723468
Van Cutsem E et al (2008) The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007. Ann Oncol 19:vi1–vi8
doi: 10.1093/annonc/mdn358
pubmed: 18539618
Aljorfi AA, Alkhamis AH (2020) A systematic review of early versus late closure of loop ileostomy. Surg Res Pract 2020:1
doi: 10.1155/2020/9876527
Tsunoda A et al (2008) Quality of life after low anterior resection and temporary loop ileostomy. Dis Colon Rectum 51(2):218–222
doi: 10.1007/s10350-007-9101-7
pubmed: 18172730
Danielsen AK et al (2017) Early closure of a temporary ileostomy in patients with rectal cancer. Ann Surg 265(2):284–290
doi: 10.1097/SLA.0000000000001829
pubmed: 27322187
Park J et al (2018) Quality of life in a randomized trial of early closure of temporary ileostomy after rectal resection for cancer (EASY trial). J Brit Surg 105(3):244–251
doi: 10.1002/bjs.10680
Keane C et al (2019) Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer. J Brit Surg 106(5):645–652
doi: 10.1002/bjs.11092
Palta M, Czito BG, Willett CG (2014 Apr) Adjuvant chemotherapy for rectal cancer—an unresolved issue. Nat Rev Clin Oncol 11(4):182–184
doi: 10.1038/nrclinonc.2014.43
pubmed: 24642673
Cercek A, Roxburgh CS, Strombom P, Smith JJ, Temple LK, Nash GM, Guillem JG, Paty PB, Yaeger R, Stadler ZK, Seier K (2018) Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol 4(6):e180071
doi: 10.1001/jamaoncol.2018.0071
pubmed: 29566109
pmcid: 5885165
Breugom AJ, Van Gijn W, Muller EW, Berglund Å, Van den Broek CB, Fokstuen T, Gelderblom H, Kapiteijn E, Leer JW, Marijnen CA, Martijn H (2015) Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo) radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial. Ann Oncol 26(4):696–701
doi: 10.1093/annonc/mdu560
pubmed: 25480874
Sun Z et al (2021) Clinical outcomes of ileostomy closure before adjuvant chemotherapy after rectal cancer surgery: an observational study from a Chinese Center. Gastroenterol Res Pract 2021:1
doi: 10.1155/2021/2368571
Bausys A et al (2019) Early versus standard closure of temporary ileostomy in patients with rectal cancer: a randomized controlled trial. J Surg Oncol 120(2):294–299
doi: 10.1002/jso.25488
pubmed: 31042015
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205
doi: 10.1097/01.sla.0000133083.54934.ae
pubmed: 15273542
pmcid: 1360123
Motamed N et al (2005) Validity and reliability of the Persian translation of the SF-36 version 2 questionnaire. EMHJ 11(3):349–357
pubmed: 16602453
Dulskas A, Petrauskas V, Kuliavas J, Bickaite K, Kairys M, Pauza K, Kilius A, Sangaila E, Bausys R, Stratilatovas E (2021) Quality of life and bowel function following early closure of a temporary ileostomy in patients with rectal cancer: a report from a single-center randomized controlled trial. J Clin Med 10(4):768
doi: 10.3390/jcm10040768
pubmed: 33671925
pmcid: 7919002
Podda M, Coccolini F, Gerardi C, Castellini G, Wilson MS, Sartelli M, Pacella D, Catena F, Peltrini R, Bracale U, Pisanu A (2022) Early versus delayed defunctioning ileostomy closure after low anterior resection for rectal cancer: a meta-analysis and trial sequential analysis of safety and functional outcomes. Int J Color Dis 37(4):737–756
doi: 10.1007/s00384-022-04106-w
Menahem B et al (2018) Early closure of defunctioning loop ileostomy: is it beneficial for the patient? A meta-analysis. World J Surg 42(10):3171–3178
doi: 10.1007/s00268-018-4603-0
pubmed: 29589116
Krand O et al (2008) Early vs. delayed closure of temporary covering ileostomy: a prospective study. Hepato-gastroenterology 55(81):142–145
pubmed: 18507094
Park J (2019) Early closure of a temporary ileostomy after rectal resection for cancer
Wang L et al (2021) Early versus late closure of temporary ileostomy after rectal cancer surgery: a meta-analysis. Surg Today 51(4):463–471
doi: 10.1007/s00595-020-02115-2
pubmed: 32833059
Elsner AT et al (2021) Closure of temporary ileostomy 2 versus 12 weeks after rectal resection for cancer: a word of caution from a prospective, randomized controlled multicenter trial. Dis Colon Rectum 64(11):1398
doi: 10.1097/DCR.0000000000002182
pubmed: 34343161
pmcid: 8492188
Massucco P, Fontana A, Mineccia M, Perotti S, Ciccone G, Galassi C, Giuffrida MC, Marino D, Monsellato I, Paris MK, Perinotti R (2021) Prospective, randomised, multicentre, open-label trial, designed to evaluate the best timing of closure of the temporary ileostomy (early versus late) in patients who underwent rectal cancer resection and with indication for adjuvant chemotherapy: the STOMAD (STOMa closure before or after ADjuvant therapy) randomised controlled trial. BMJ Open 11(2):e044692
doi: 10.1136/bmjopen-2020-044692
pubmed: 33608405
pmcid: 7896613
Copaescu C, Smeu B, Catanescu E, Andrei D, Tomulescu V (2019) Early laparoscopic ileostomy reversal after rectal cancer surgery-technique and outcomes. Chirurgia (Bucur) 114(3):392–400
doi: 10.21614/chirurgia.114.3.392
pubmed: 31264578